Literature DB >> 9029094

TGF-beta 1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis.

E Riedl1, H Strobl, O Majdic, W Knapp.   

Abstract

Our previous studies demonstrated that TGF-beta 1 is required for efficient in vitro generation of dendritic cells (DC) from CD34+ progenitor cells under serum-free conditions. Here we show that TGF-beta 1 promotes the growth and differentiation of DC primarily by protecting the viability of DC precursors and not by enhancing their proliferative response. Addition of TGF-beta 1 to TNF-alpha, granulocyte-macrophage CSF, and stem cell factor-supplemented cultures had no significant effect on the proportions of cycling cells. Already at 72 h of culture, however, the proportion of apoptotic cells was reduced by more than 60% in the presence of TGF-beta 1. This early protective effect of TGF-beta 1 correlates with the outgrowth of higher numbers and proportions of CD1a+ DC at day 7 of culture. It also correlates with a significantly reduced Fas/APO-1 expression on TGF-beta 1 cultured cells. In contrast, granulomonocytic cells, also arising under these culture conditions, are not affected to such an extent. They are found at equal proportions, both in the presence and absence of TGF-beta 1. The striking DC growth-promoting effect of TGF-beta 1 could only be observed when both TGF-beta 1 and TNF-alpha were present in the cultures. TGF-beta 1, in the absence of TNF-alpha, rather inhibited than enhanced cell expansion. Thus, for optimal in vitro DC development to occur, all four cytokines must obviously act in concert and the combination of TGF-beta 1 with TNF-alpha seems to be particularly critical.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029094

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Dose-dependent changes in influenza virus-infected dendritic cells result in increased allogeneic T-cell proliferation at low, but not high, doses of virus.

Authors:  SangKon Oh; J Michael McCaffery; Maryna C Eichelberger
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Functional and phenotypic characterization of distinct porcine dendritic cells derived from peripheral blood monocytes.

Authors:  R Paillot; F Laval; J C Audonnet; C Andreoni; V Juillard
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

3.  Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions.

Authors:  L Matera; A Galetto; M Geuna; K Vekemans; E Ricotti; M Contarini; F Moro; G Basso
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

4.  Severe dermatitis with loss of epidermal Langerhans cells in human and mouse zinc deficiency.

Authors:  Tatsuyoshi Kawamura; Youichi Ogawa; Yuumi Nakamura; Satoshi Nakamizo; Yoshihiro Ohta; Hajime Nakano; Kenji Kabashima; Ichiro Katayama; Schuichi Koizumi; Tatsuhiko Kodama; Atsuhito Nakao; Shinji Shimada
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

5.  A role for TGFbeta1 in langerhans cell biology. Further characterization of the epidermal Langerhans cell defect in TGFbeta1 null mice.

Authors:  T A Borkowski; J J Letterio; C L Mackall; A Saitoh; X J Wang; D R Roop; R E Gress; M C Udey
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

6.  Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance.

Authors:  T Chodon; T Sugihara; H H Igawa; E Funayama; H Furukawa
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

7.  Viral interleukin-10 expressed by human cytomegalovirus during the latent phase of infection modulates latently infected myeloid cell differentiation.

Authors:  Selmir Avdic; John Z Cao; Allen K L Cheung; Allison Abendroth; Barry Slobedman
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

8.  TGF-beta1 dampens the susceptibility of dendritic cells to environmental stimulation, leading to the requirement for danger signals for activation.

Authors:  Tomoyuki Ohtani; Masato Mizuashi; Satoshi Nakagawa; Yoshinori Sasaki; Taku Fujimura; Ryuhei Okuyama; Setsuya Aiba
Journal:  Immunology       Date:  2009-04       Impact factor: 7.397

Review 9.  Role of transforming growth factor-beta in hematologic malignancies.

Authors:  Mei Dong; Gerard C Blobe
Journal:  Blood       Date:  2006-02-16       Impact factor: 22.113

10.  Increased serum transforming growth factor-beta1 in human colorectal cancer correlates with reduced circulating dendritic cells and increased colonic Langerhans cell infiltration.

Authors:  A Huang; J W Gilmour; N Imami; P Amjadi; D C Henderson; T G Allen-Mersh
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.